A 48-year-old female with generalized anxiety disorder and a history of alcohol use disorder in sustained remission requests augmentation of her partially effective SSRI. The PMHNP considers adding a gabapentinoid but is concerned about substance misuse history. The patient asks whether gabapentin or pregabalin would be safer given her recovery. Which of the following best guides this prescribing decision?